BU ADC Current News

The cutting-edge work of our center and researchers receives attention from both regional and national media. Check out our latest headlines and keep up to date with notable Alzheimer’s news from around the globe!


Study identifies 2 new genes responsible for Alzheimer’s disease among African-Americans

(Boston)–Researchers have identified two new genetic risk factors for Alzheimer’s disease (AD) among African Americans.

The findings, which appear online in the journal Alzheimer’s and Dementia, may lead to the development of new therapies specifically targeting those genes.

“There are currently no medications for AD that slow or stop the progression of the disease. Genes that increase risk for AD are potential targets for new disease-modifying AD drug therapies. Our study identifies two potentially “drugable” targets,” explains corresponding author Jesse Mez, MD, MS, assistant professor of neurology at BUSM and associate director of the Boston University Alzheimer’s Disease & CTE Center Clinical Core.

Click here to for full transcript


BudsonAndrewDr. Andrew Budson, Appointed to the Board of Directors of the Alzheimer’s Association MA/NH Chapter

Dr. Andrew Budson is currently the Associate Chief of Staff for Education at VA Boston Healthcare System and Associate Director of the Education Core and Associate Director for the Boston University Alzheimer’s Disease Center. He is also the principal investigator of the Center for Translational Cognitive Neuroscience at VA Boston, where his research seeks to understand false memories in Alzheimer’s disease, and different non-invasive methods that could improve memory in patients with Alzheimer’s disease.


Kate Turk

Dr. Katherine Turk is Awarded an Alzheimer’s Association Clinical Fellowship Award 

Dr. Katherine Turk, an instructor in Neurology at BUSM and physician scientist pursuing fellowship training at VA Boston has been awarded the Alzheimer’s Association Clinical Fellowship Award for her project in the lab of Dr. Andrew Budson, using event related potentials to diagnose Alzheimer’s disease in the clinic. The funding of $150,000 over three years allows extension of the project to include Amyloid PET scans for participants as well as quantitative MRI techniques. Ultimately the project will compare diagnosis of Alzheimer’s disease using event related potential techniques to Amyloid PET techniques as a gold standard.


Screenshot 2016-08-01 10.13.28

Dr. Tsuney Ikezu Receives an Award from the Alzheimer’s Association for his Research

Tsuneya Ikezu, MD, PhD, professor of pharmacology & experimental therapeutics and neurology at Boston University School of Medicine (BUSM), recently received the Alzheimer’s Association’s Inge Grundke-Iqbal Award for Alzheimer’s Research. The award was presented at the Alzheimer’s Association International Conference® 2016 in Toronto.

Click here for full transcript


Screenshot 2016-07-28 11.31.34

$1.49 Million NIH Grant to fun Start up that develops therapeutics to protect against Alzheimer’s Disease

 Dr. Carmela Abraham and her husband Menachem win $1.49 million NIH grant to fund their company that is working towards developing novel therapeutics to protect against Alzheimer’s disease.

“She came home from her lab one day and said she wanted to start a company to develop novel therapeutics to protect against Alzheimer’s disease.”

Click here to learn more about their journey.


Screenshot 2016-04-25 09.20.31Boston University Alzheimer’s Disease Center Three Part Series

Screenshot 2016-04-25 08.56.26

Click on the image above to learn more about BU ADC research

“I think the goal of medicine is to reduce the pain of mankind. I strongly believe that,” says Dr. Qiu, BU ADC faculty member.


Screenshot 2016-04-08 10.24.00

Alzheimer’s ravages the minds of over 40 million victims worldwide. Join scientists as they untangle the cause of this tragic illness, and go behind the scenes of major drug trials to discover the therapies that may slow and even prevent the disease.

PBS Nova “Can Alzheimer’s Be Stopped?” Premieres Wednesday, April 13, 2016 at 9pm ET/8C on PBS.

Want to make a difference in the fight against Alzheimer? To see if you qualify contact Boston University Alzheimer’s Disease Center, 617-414-1077. Now is the time!

Click here to learn more about the A4 Study.


Gift Recognizes Family’s Struggle with Alzheimer’s

Screen Shot 2016-02-24 at 4.12.58 PMA heartfelt story about a loving family and the reason why they chose to contribute to our research through a generous gift.

“We all wanted to honor my father, but we also wanted to do something for BU, since he had so loved it.”

Click here for full story


Screenshot 2016-02-11 10.39.20Incidence of ‪‎Dementia‬ over Three Decades in the Framingham Heart Study

Dr. Sudha Seshadri, an investigator at Boston University Alzheimer’s Disease Center and ‪‎Framingham‬ ‪‎Heart‬ Study, along with colleagues published a paper in The New England Journal of ‪‎Medicine‬. The paper is titled, Incidence of ‪‎Dementia‬ over Three Decades in the Framingham Heart Study‬.

Click Here for Full Transcript


DSC_0839 Dr. Jesse Mez Receives Funding from the Alzheimer’s Association

January 14th, 2016
Venue: VA Boston Healthcare System

Dr. Jesse Mez, Associate Director of the Clinical Core at Boston University Alzheimer’s Disease Center was presented with a check from the Alzheimer’s Association to support his research in genetics.


mckee-130x150Congratulations Dr. Ann McKee

Professor of Neurology & Pathology, Director, Neuropathology Core

Awarded the Boston University School of Medicine Jack Spivack Excellence in Neurosciences Award of 2016.

Click Here for Description of Award

 


$ 16 Million Dollar Grant Awarded to Dr. Robert Stern

h_butoday_Stern-BobBoston University Alzheimer’s Disease Center (BU ADC)/Chronic Traumatic Encephalopathy (CTE) Program is excited to announce that Dr. Robert Stern, professor of neurology, neurosurgery, and anatomy and neurobiology at BU School of Medicine (MED), and clinical core director for the BU ADC/CTE Program has been awarded a $16 million dollar grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) to develop methods for diagnosing CTE‬ during life.

Stern describes the project as “the biggest study of CTE in living subjects to date, in terms of the scope of the science, the number of participants, the breadth and depth and size of the group of investigators, and the amount of the grant.”

And because CTE shares certain features of Alzheimer’s and other neurodegenerative diseases, says Stern, the study will benefit research beyond the field of CTE. “We expect what we learn from this project will have a tremendous impact on the understanding of those other diseases,” he notes.

Continue for full transcript


Published Findings From Very First NINDS/NIBIB Consensus Hosted at Boston University Alzheimer’s Disease Center

McKee Photo_High Resolution_2

December 15th, 2015

Dr. Ann McKee, Neuropathology Core Director and Associate Director of the Boston University Alzheimer’s Disease Center/ CTE Program along with colleagues published a paper introducing evidence from their first NINDS/NIBIB consensus meeting that defined neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.

Click Here for Publication


Study Helps Veternas Age

There is good news and bad news when it comes to aging wisely.  First, the bad news: no magic pill portion can keep you physicaly and mentally robust into your golden years.  The good news is Veterans have Dr. Maureen O’Connor on their side, helping them understand what normal aging is like providing tips to keep their brain health at any age

Click here for full article


Groundbreaking documentary on Art and Alzheimer’s airs nationwide on public television in 2015

indexI Remember Better When I Paint shows how the creative arts can enhance the quality of life for people with Alzheimer’s. The program continues to broadcast on public television stations nationwide in 2015, in particular at the end of October and also in November which is National Alzheimer’s Awareness Month in the US.

Leading doctors‬ and neurologists explain how parts of the brain‬ can be spared and discuss the life-enriching benefits of these new approaches. Among these experts is, Dr. Robert Stern, Boston University Alzheimer’s Disease Center Clinical Core Director.

Click here to learn more


The Wingate Residences Announces Partnership with Boston University School of Medicine and Its Alzheimer’s Disease and CTE Center (BU ADC)

October 5, 2015, Needham, MA – The Wingate Residences, a leading senior living community located on the Wingate at Needham campus in Needham, Massachusetts, today announced its partnership with Boston University School of Medicine and their Alzheimer’s Disease and CTE Center (BU ADC).  This partnership aligns with Wingate’s Memory Care 360˙ program mission to enhance the lives of seniors coping with Alzheimer’s and dementia-related diseases. Click Here to Learn More


Dr. Jesse Mez Receives an Alzheimer’s Association Grant Award

Dr. JessIMG_0984e Mez, Associate Director of the Clinical Core at Boston University Alzheimer’s Disease Center was presented with an Alzheimer’s Association research grant last night at the Simons Symposium. This event was held by the Alzheimer’s Association and was open to the community.

 

 

 

 


Dudley Allen Sargent Lecture: Dr. Stern attracts 300

DudleyAllenSargent_Lecture2015_0213Dr. Stern was invited to give a lecture on CTE at Sargent College on October 1st. Appropriate for rehabilitation school setting, the presentation focused on the long term effects of repetitive head injuries. As a major public health concern for our country, the brain disease CTE can lead to many health concerns. The importance of protective one’s head is often underestimated, especially when it comes to America’s favor its past times. Dir. Stern’s goal was to raise awareness and provide updates on what his research is work towards.

Click here to view full presentation

 


A Light at the End of the Tunnel for Alzheimer’s? Dr. Stern says it may be coming

NC5_BNL_hExcerpt: “Stern said that T-817MA could also go a step further and protect brain cells from destruction of Alzheimer’s disease, which leads to dementia. ‘The changes in the brain in Alzheimer’s disease start maybe 20 years before the first symptoms and then get worse and worse as the disease gets further along,” said Stern. “If this drug would work, it would slow that progression so the person would be able to maintain a much better quality of life without deteriorating.’ Stern said that would be a game changer for patients and their caregivers.”

Click here for full transcript


 Exercise and Social Networking: Two Strategies to Work Out your Brain
CBS Boston News

Excerpt: “Doing something surrounded by people, interacting with people. The research does suggest that that has some ability to keep the brain healthy as we get older. Anything is better than nothing. Anything is better than isolation.

Click here for full transcript